BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Thursday reported a loss of $22.8 million in its first quarter.

On a per-share basis, the Burlingame, California-based company said it had a loss of 58 cents. Losses, adjusted for non-recurring costs, were 45 cents per share.

The biopharmaceutical company posted revenue of $603,000 in the period.

In the final minutes of trading on Thursday, the company's shares hit $4.53. A year ago, they were trading at $9.27.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN

Automated Insights, source Associated Press News